I am a molecular and cellular biologist trained at Harvard Medical School, currently holding an academic appointment as assistant professor at Cedars-Sinai. In my scientific career, I have been researching the cell-autonomous and non-cell-autonomous contributions to cancer and have focused my investigations specifically on leukemia and sarcoma.
Sarcomas are heterogeneous tumors that originate from cells belonging to the mesenchymal lineages. With the aim of identifying new and more effective therapies for these tumors, the Guarnerio Laboratory has developed a sarcoma genetic platform that offers multiple advantages when compared with other protocols.
Learn more about the scientists, faculty members, investigators and other healthcare professionals of the Guarnerio Laboratory, whose dedicated efforts lead to groundbreaking discoveries.
Guarnerio J, Mendez LM, Asada N, Menon AV, Fung J, Berry K, Frenette PS, Ito K, Pandolfi PP.
Nat Commun. 2018 Jan 4;9(1):66.
German NJ, Yoon H, Yusuf RZ, Murphy JP, Finley LW, Laurent G, Haas W, Satterstrom FK, Guarnerio J, Zaganjor E, et al.
Mol Cell. 2016 Sep 15;63(6):1006-1020.
Guarnerio J, Bezzi M, Jeong JC, Paffenholz SV, Berry K, Naldini MM, Lo-Coco F, Tay Y, Beck AH, Pandolfi PP.
Cell. 2016 Apr7;165(2):289-302.